Skip to main content
SpringerLink
Log in

Tissue-Type Plasminogen Activator

Therapeutic Potential in Thrombotic Disease States

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Agnelli G, Buchanan MR, Fernandez F, Boneu B, Van Ryn J, et al. A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. Circulation 72: 178–182, 1985

    Article  PubMed  CAS  Google Scholar 

  • Astrup T. Tissue activators of plasminogen. Federation Proceedings 25: 42–51, 1966

    PubMed  CAS  Google Scholar 

  • Banyai L, Varadi A, Patthy L. Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator. FEBS Letters 163: 37–41, 1983

    Article  PubMed  CAS  Google Scholar 

  • Bergmann SR, Fox KAA, Ter-Pogossian MM, Sobel BE, Collen D. Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science 220: 1181–1183, 1983

    Article  PubMed  CAS  Google Scholar 

  • Carlin G, Einarsson M, Saldeen T. Tissue plasminogen activator effectively lyses intravascular fibrin deposits in the rat lung. In Davidson et al. (Eds). Progress in fibrinolysis, Vol. 6, pp. 471–474, Churchill Livingstone, Edinburgh, 1983

    Google Scholar 

  • Collen D. On the regulation and control of fibrinolysis. Thrombosis and Haemostasis 43: 77–89, 1980

    PubMed  CAS  Google Scholar 

  • Collen D, Rijken DC, Van Damme J, Billiau A. Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo. Thrombosis and Haemostasis 48: 294–296, 1982

    PubMed  CAS  Google Scholar 

  • Collen D, Stassen JM, Marafino B, Builder S, De Cock F, et al. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells. Journal of Pharmacology and Experimental Therapeutics 231: 146–152, 1984

    PubMed  CAS  Google Scholar 

  • Collen D, Stassen JM, Verstraete M. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration. Journal of Clinical Investigation 73: 368–376, 1983

    Article  Google Scholar 

  • Collen D, Topol EJ, Tiefenbrunn AJ, Gold HK, Weisfeldt ML, et al. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Circulation 70: 1012–1017, 1984

    Article  PubMed  CAS  Google Scholar 

  • Flameng W, Van De Werf F, Vanhaecke J, Verstraete M, Collen D. Coronary thrombolysis and infarct size reduction following intravenous infusion of recombinant tissue-type plasminogen activator in non-human primates. Journal of Clinical Investigation 75: 84–90, 1985

    Article  PubMed  CAS  Google Scholar 

  • Gold HK, Fallon JT, Yasuda T, Khaw BA, Newell JB, et al. Coronary thrombolysis with recombinant human tissue plasminogen activator. Circulation 70: 700–707, 1984

    Article  PubMed  CAS  Google Scholar 

  • Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. Journal of Biological Chemistry 257: 2912–2919, 1982

    PubMed  CAS  Google Scholar 

  • Korninger C, Matsuo O, Suy R, Stassen JM, Collen D. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis. Journal of Clinical Investigation 69: 573–580, 1982

    Article  PubMed  CAS  Google Scholar 

  • Liu CY, Wallen P. The binding of tissue plasminogen activator by fibrin. (Abstract.) Circulation 70: 365, 1984

    Google Scholar 

  • Matsuo O, Rijken DC, Collen D. Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus. Nature 291: 590–591, 1981

    Article  PubMed  CAS  Google Scholar 

  • Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301: 214–221, 1983

    CAS  Google Scholar 

  • Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. Journal of Biological Chemistry 256: 7035–7041, 1981

    PubMed  CAS  Google Scholar 

  • Rijken DC, Hoylaerts M, Collen D. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. Journal of Biological Chemistry 257: 2920–2925, 1982

    PubMed  CAS  Google Scholar 

  • Rijken DC, Wijngaards G, Zaal-de Jong M, Welbergen J. Purification and partial characterization of plasminogen activator from human uterine tissue. Biochemica Biophysica Acta 580: 140–153, 1979

    Article  CAS  Google Scholar 

  • The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. New England Journal of Medicine 312: 932–936, 1985

    Google Scholar 

  • Van De Werf F, Bergmann SR, Fox KAA, De Geest H, Hoyng CF, et al. Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. Circulation 69: 605–610, 1984

    Article  PubMed  Google Scholar 

  • Van De Werf F, Ludbrook PA, Bergmann SR, Tiefenbrunn AJ, Fox KAA, et al. Clot selective coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. New England Journal of Medicine 310: 609–613, 1984

    Article  PubMed  Google Scholar 

  • Verstraete M, Bernard R, Bory M, Brower RW, Collen D, et al. Randomized trial of intravenous recombinant human tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1: 842–848, 1985

    Article  PubMed  CAS  Google Scholar 

  • Verstraete M, Collen D. Thrombolytic properties of tissue-type plasminogen activator in venous thrombosis. In Collen et al. (Eds). Thrombolysis: biological and therapeutic properties of new thrombolytic agents, Churchill-Livingstone, Edinburgh, in press, 1985

    Google Scholar 

  • Weimar W, Stibbe J, Van Seyen AJ, Billiau A, De Somer P, et al. Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator. Lancet 2: 1018–1020, 1981

    Article  PubMed  CAS  Google Scholar 

  • Wiman B, Collen D. On the kinetics of the reaction between human antiplasmin and plasmin. European Journal of Biochemistry 84: 573–578, 1978

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Biochemistry and Medicine, College of Medicine, University of Vermont, Health Science Complex, Given Building, Burlington, VT, 05405-0068, USA

    D. Collen

  2. Center for Thrombosis and Vascular Research, University of Leuven, Leuven, Belgium

    D. Collen

Authors
  1. D. Collen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Collen, D. Tissue-Type Plasminogen Activator. Drugs 31, 1–5 (1986). https://doi.org/10.2165/00003495-198631010-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198631010-00001

Search

Navigation